Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patientsD Lorusso, G Ferrandina, S Greggi, et al.
Gynecologic Oncology|July 25, 2020
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control studyD Lorusso, C Marchetti, C Conte, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapyS Pignata, F Amant, G Scambia, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2012
Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric studyF Zanaboni, B Grijuela, S Giudici, et al.
British Journal of Cancer|June 13, 2013
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovaryG Mangili, J Ottolina, A Gadducci, et al.
Critical Reviews in Oncology/Hematology|March 19, 2025
Management of early-stage ovarian cancer: Open questions and debated issuesV Salutari, E Giudice, E Rapisarda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.
British Journal of Cancer|May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II studyV Adamo, V Lorusso, R Rossello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialL Gladieff, A Ferrero, G De Rauglaudre, et al.
ESMO Open|February 18, 2021
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in ItalyR Berardi, M Torniai, M S Cona, et al.
Pageof 15